Dexmedetomidine Hydrochloride
Drugdexmedetomidine iv bolus followed by the infusion of 0.1-1 ug/kg/hr during general anesthesia
Other names: precedex
NCT Number: NCT04409964
This study is performed to investigate the effect of opioid-free general anesthesia on the recovery quality after gynecological laparoscopy.
Looking for future studies?
Notify Me20 year–65 year
Female
Interventional
Not applicable
Seoul St.Mary's Hospital, Seoul, Seocho-gu, South Korea
The quality of recovery after the surgery is assessed using the QoR 40. In addition, the various kinds of cytokine are assessed for the ancillary study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
dexmedetomidine iv bolus followed by the infusion of 0.1-1 ug/kg/hr during general anesthesia
Other names: precedex
lidocaine iv bolus followed by the infusion of 1.5 mg/kg/hr during general anesthesia
Other names: lidocaine
remifentanil iv infusion of 0.5-5 ng/ml (effect site concentration using TCI) during general anesthesia
Other names: remifentanil
Time frame: at 24 hour after the completion of surgery
The quality of recovery is assessed using questionnaire. This questionnaire includes 40 items. The score range is from 40 to 200. The higher score means the better quality of recovery after surgery.
Time frame: during surgery
as ancillary study, to assess the various kinds of cytokines such as epinephrine, norepinephrine, interleukin-10, tumor necrosis factor-alpha.
The Catholic University of Korea
Other
the Effect of Opioid-free General Anesthesia on the Recovery Quality After Gynecological Laparoscopy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06875518
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Damietta, New Damietta, Egypt
View Trial DetailsNCT07292324
Chronic Post Surgical Pain, Female Urogenital Diseases
Denpasar, Bali, Indonesia
View Trial DetailsNCT05897385
Agnosia, Female Urogenital Diseases
Kuala Lumpur, Malaysia
View Trial DetailsNCT06536192
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Karabük, Karabük Province, Turkey (Türkiye)
View Trial Details